Is Albert Labs International Corp. (ABRT.CN) a Buy, Sell, or Hold?
Albert Labs International Corp.
CNQ:ABRT.CN
$0.005 CAD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 5.6K
- Market Capitalization
- $372.07K
- P/E Ratio
- -0.04
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.04
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.17
Industry, Sector & symbol
| Stock Exchange | CNQ |
| CEO | Navchand Jagpal |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | ABRT.CN |
| CUSIP | 012784104 |
| CIK | None |
| Web | https://albertlabs.com |
| Phone | 778-819-0740 |
| Currency | CAD |
| Employees | None |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.17 |
| Quick Ratio | 0.17 |
| Cash Ratio | 0.15 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.03 |
| Price / Cash Flow | -0.25 |
| Price / Book | -0.77 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.13 |
| Trailing P/E Ratio | -0.04 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-7.06M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 1626.75% |
| Return on Assets | -4310.49% |
Financials Score
| AltmanZ Score | -342.55 |
| Piotroski Score | 1.00 |
| Working Capital | -494.87K |
| Total Assets | 64.62K |
| Ebit | -2.32M |
| Market Cap | 372.07K |
| Total Liabilities | 507.7K |
Poll Results
About Albert Labs International Corp. (CNQ:ABRT.CN) Stock
Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada. ...
Frequently Asked Questions
-
What is the current Albert Labs International Corp. (ABRT.CN) stock price?
-
Albert Labs International Corp.(CNQ:ABRT.CN) stock price is $0.005 in the last trading session. During the trading session, ABRT.CN stock reached the peak price of $0.035 while $0.005 was the lowest point it dropped to. The percentage change in ABRT.CN stock occurred in the recent session was 0.0% while the dollar amount for the price change in ABRT.CN stock was $0.
-
ABRT.CN's industry and sector of operation?
-
The CNQ listed ABRT.CN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ABRT.CN?
-
Toby Campbell Sorabjee | Chief Communications Officer
Navchand Jagpal | Acting Chief Executive Officer, Chief Financial Officer & Director
Toby Sorabjee | Chief Communications Officer
Santoke Naal | Chief Operating Officer
Malcolm Barratt-Johnson | Chief Medical Officer -
How many employees does ABRT.CN have?
-
Number of ABRT.CN employees currently stands at None. ABRT.CN operates from 6996 Merritt Avenue, Burnaby, BC V5J 4R6, CA.
-
Link for ABRT.CN official website?
-
Official Website of ABRT.CN is: https://albertlabs.com
-
How do I contact ABRT.CN?
-
ABRT.CN could be contacted at phone #778-819-0740 and can also be accessed through its website. ABRT.CN operates from 6996 Merritt Avenue, Burnaby, BC V5J 4R6, CA.
-
How many shares of ABRT.CN are traded daily?
-
The average number of ABRT.CN shares traded daily for last 3 months was 5.6K.
-
What is the market cap of ABRT.CN currently?
-
The market value of ABRT.CN currently stands at $372.07K with its latest stock price at $0.005